Andreas holds a PhD in plant biotechnology. Before joining Eleva as research scientist in 2009, he held positions at the University of Münster and Freiburg, Germany. At Eleva, Andreas was responsible for advancing BryoTechnology to a fully viable biopharmaceutical platform. Andreas has been Chief Scientific Officer since 2015 and was appointed Managing Director at the end of 2019.